A study using breast SkBr3, colorectal LoVo, hepatocarcinoma HepG2 cancer cells, and breast cancer-associated fibroblasts suggested that GPER is involved in regulating fatty acid synthase (FASN) expression and activity in cancer cells and cancer-associated fibroblasts, which contributes to cancer progression [112]. Here, FASN is linked to breast carcinoma.